Daniel Ghinn discusses the possible positive outcomes to Boehringer Ingelheim’s Syrum, the highly-anticipated pharmaceutical social game, ahead of its launch this week. Ever since Boehringer ...

Boehringer Ingelheim was an early adopter of Medidata's electronic data collection (EDC) platform for clinical trials, and has now extended and expanded the contract.

Boehringer Ingelheim Pharma GmbH & Co KG has selected a third oncology drug candidate to advance into IND-enabling studies under its ongoing collaboration with Oxford Biotherapeutics Ltd.

Boehringer Ingelheim, a global leader in animal health, has announced the launch of its latest poultry vaccine in India—a single-dose, next-generation solution that provides protection against Bursal, ...

Boehringer Ingelheim remains confident about its future business development in China, which it considers to be one of its most important markets and a source of innovation, company executives said ...